BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2022 6:41:14 AM | Browse: 505 | Download: 1115
 |
Received |
|
2021-10-22 04:41 |
|
Peer-Review Started |
|
2021-10-22 04:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-01 05:04 |
|
Revised |
|
2021-12-11 08:55 |
|
Second Decision |
|
2022-01-13 01:01 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-01-13 01:43 |
|
Articles in Press |
|
2022-01-13 01:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-01-13 09:17 |
|
Publish the Manuscript Online |
|
2022-01-22 06:41 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Semra Demirli Atici and Erdinc Kamer |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Semra Demirli Atici, MD, Surgeon, Department of General Surgery, University of Health Sciences Tepecik Training and Research Hospital, Güney Mahallesi, 1140/1 Sokak No:1 Yenişehir/Konak, İzmir 35180, Türkiye. smrdemirli@hotmail.com |
| Key Words |
Colorectal cancer; Carbohydrate antigen 19-9; Liver metastasis of colorectal cancer; Synchronous liver metastasis; Chemotherapy; Metastatic colorectal cancer |
| Core Tip |
It is important to evaluate synchronous liver metastases of colorectal cancer (CRC) and to determine the response to chemotherapy in patients. Based on findings from such, the optimal treatment method is selected for each patient. The scoring system described in the study, created through a combination of radiology and laboratory parameters, can guide treatment. However, we think that it would be more appropriate to discuss the results of this study in the context of other studies conducted with patients with stage IV CRC. |
| Publish Date |
2022-01-22 06:41 |
| Citation |
Demirli Atici S, Kamer E. Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? World J Gastroenterol 2022; 28(4): 500-501 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i4/500.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i4.500 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
